Novartis AG (NVSEF)
Novartis Market Cap: 264.13B for Jan. 13, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Roche Holding AG | 339.80B |
| BeOne Medicines Ltd. | 38.86B |
| AC Immune SA | 371.72M |
| CRISPR Therapeutics AG | 5.361B |
Market Cap Related Metrics
| PE Ratio | 18.82 |
| PS Ratio | 4.991 |
| Price to Book Value | 5.958 |
| Price to Free Cash Flow | 15.37 |
| Price | 137.66 |
| Earnings Yield | 5.31% |
| Operating PE Ratio | 15.73 |
| Normalized PE Ratio | 17.88 |